RoboStrategy to Issue 19.6 Million Shares, Signaling Significant Dilution
BOT sits 68% above its 52-week low of $19.2 on elevated volume (2.0× avg).
Summary
RoboStrategy, Inc. filed a prospectus supplement for the issuance of 19.6 million shares of common stock, representing substantial dilution for existing shareholders, following its recent NASDAQ listing.
Key Events · Financing and Capital Events · BOT
-
Significant Share Issuance
RoboStrategy, Inc. is issuing 19,655,968 shares of common stock, which will result in substantial dilution for current shareholders.
-
Post-IPO Capital Raise
This issuance occurs shortly after the company's NASDAQ listing on May 11, 2026, and follows the announcement of a committed equity facility on May 13, 2026, indicating a rapid capital infusion post-IPO.
-
Updated Portfolio Details
The filing also includes an updated Net Asset Value of $7.31 per share and details of the company's investment portfolio as of March 31, 2026.
Analysis · BOT · Unknown
RoboStrategy, Inc. has filed a prospectus supplement for the issuance of 19,655,968 shares of common stock. This represents a substantial capital raise that will lead to significant dilution for existing shareholders. This action follows the company's recent NASDAQ listing on May 11, 2026, and the establishment of a committed equity facility on May 13, 2026, indicating a rapid move to secure capital post-IPO. The filing also provides an updated Net Asset Value and details of its investment portfolio.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 43.9% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BOT was trading at $32.21 on NASDAQ in the Unknown sector, with a market capitalization of approximately $730.1M. The 52-week trading range was $19.20 to $59.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.